Rondonotti Emanuele, Andrealli Alida, Amato Arnaldo, Paggi Silvia, Conti Clara Benedetta, Spinzi Giancarlo, Radaelli Franco
a Gastroenterology Unit , Ospedale Valduce , Como , Italy.
b Università degli Studi , Milan , Italy.
Expert Rev Gastroenterol Hepatol. 2016 Dec;10(12):1349-1358. doi: 10.1080/17474124.2016.1245143. Epub 2016 Oct 19.
Adenoma detection rate (ADR) is the most robust colonoscopy quality metric and clinical studies have adopted it as the ideal method to assess the impact of technical interventions. Areas covered: We reviewed papers focusing on the impact of colonoscopy technical issues on ADR, including withdrawal time and technique, second evaluation of the right colon, patient positional changes, gastrointestinal assistant participation during colonoscopy, water-aided technique, optimization of bowel preparation and antispasmodic administration. Expert commentary: Overall, technical interventions are inexpensive, available worldwide and easy to implement. Some of them, such as the adoption of split dose regimen and slow scope withdrawal to allow a careful inspection, have been demonstrated to significantly improve ADR. Emerging data support the use of water-exchange colonoscopy. According to published studies, other technical interventions seem to provide only marginal benefit to ADR. Unfortunately, the available evidence has methodological limitations, such as small sample sizes, the inclusion of expert endoscopists only and the evaluation of single technical interventions. Additionally, larger studies are needed to clarify whether these interventions might have a higher benefit on low adenoma detectors and whether the implementation of a bundle of them, instead of a single technical maneuver, might have a greater impact on ADR.
腺瘤检出率(ADR)是最可靠的结肠镜检查质量指标,临床研究已将其作为评估技术干预效果的理想方法。涵盖领域:我们回顾了聚焦于结肠镜检查技术问题对ADR影响的论文,包括退镜时间和技术、右半结肠的二次评估、患者体位改变、结肠镜检查期间胃肠助手的参与、水辅助技术、肠道准备的优化以及抗痉挛药物的使用。专家评论:总体而言,技术干预成本低廉、全球通用且易于实施。其中一些干预措施,如采用分剂量方案和缓慢退镜以进行仔细检查,已被证明可显著提高ADR。新出现的数据支持使用水交换结肠镜检查。根据已发表的研究,其他技术干预措施似乎对ADR仅提供边际效益。不幸的是,现有证据存在方法学局限性,如样本量小、仅纳入专家内镜医师以及对单一技术干预措施的评估。此外,需要开展更大规模的研究,以阐明这些干预措施对低腺瘤检出者是否可能具有更高的效益,以及实施一系列干预措施而非单一技术操作是否可能对ADR产生更大影响。